"10.1371_journal.pone.0080006","plos one","2013-11-20T00:00:00Z","Jenell R Smith; Peter P Syre; Shaina A Oake; Kristen J Nicholson; Christine L Weisshaar; Katrina Cruz; Robert Bucki; Bethany C Baumann; Paul A Janmey; Beth A Winkelstein","Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: PAJ BAW. Performed the experiments: JRS PPS CLW KC SO BB RB. Analyzed the data: JRS KJN KC SO BB RB. Contributed reagents/materials/analysis tools: BAW PAJ. Wrote the paper: JRS PAJ BAW.","Paul Janmey is on the advisory board of Sea Run Holdings Inc., who supported the work leading to data in figures 1, 2 and 8. Beth Winkelstein and Paul Janmey are also co-applicants with Sea Run Holdings on a patent application based on the use of salmon thrombin. The patent application (# 12/582,040) entitled “Method of using salmon thrombin to alleviate central nervous system mediated pain” was filed on October 20, 2009. It is true that this does not alter the authors’ adherence to all PLOS ONE policies on sharing data and materials.","2013","11","Jenell R Smith","JRS",10,TRUE,2,7,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
